Director/PDMR Shareholding

RNS Number : 6064Q

Smith & Nephew Plc

21 February 2023

 

SMITH & NEPHEW PLC

21 February 2023

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM.

Smith & Nephew plc (the "Company") announces that it has been informed of changes to the share interests of PDMRs in the Company, detailed below, following completion of the related performance periods.

Smith & Nephew Global Share Plan 2020 (Performance Share Awards):

The following relates to individuals included in the below notification:

Reason for the notification
Initial notification /Amendment	Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name	Smith & Nephew plc
LEI	213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument	Smith & Nephew plc ordinary shares of USD 0.20 each
Identification code	ISIN: GB0009223206
Nature of the transaction	Lapse of Performance Share Awards granted on 21 May 2020 under the Smith & Nephew Global Share Plan 2020
Date of Transaction	2023 - 02 - 21
Place of Transaction	Lapse took place outside a trading venue

Name of PDMR (Position)	Number of ordinary shares under award granted on 21/05/2020 (shown at maximum)	Number of ordinary shares lapsed under award (shown at maximum)	Number of ordinary shares outstanding under award (shown at maximum)
Helen Barraclough (Group General Counsel & Company Secretary)	10,982	10,982	0
Bradley Cannon ( President Orthopaedics, Sports Medicine & ENT and Americas)	29,624	29,624	0
Phil Cowdy (Chief Corporate Development & Corporate Affairs Officer)	19,860	19,860	0
Myra Eskes (President APAC Region & Global Service)	29,392	29,392	0
Simon Fraser (President Advanced Wound Management & Global Commercial Operations)	25,628	25,628	0
Elga Lohler (Chief HR Officer)	26,472	26,472	0
Vasant Padmanabhan (President Research & Development)	25,638	25,638	0

Notes:

(i)  Following completion of the performance measurement period, these awards lapsed in full on 21 February 2023.

(ii)  Details regarding the performance against targets as set at the grant date will be disclosed within the Annual Report which is to be published on 6 March 2023.

This announcement is made in accordance with the requirements of Article 19 (3) of the Market Abuse Regulation.

Sarah Carne  

Deputy Company Secretary

Smith & Nephew plc

Tel:  [phone]

 

END

 

 

DSHFLFVVFTILFIV